Literature DB >> 1180751

Spontaneous hyphema and vessel anomaly.

H Savir, R S Manor.   

Abstract

We describe a case of spontaneous hyphema, in which results of fluorescein angiography revealed that the condition was caused by anomalous iris vessels. A cavernous hemangloma of the ipsilateral orbit was discovered. We stress the importance of performing fluorescein angiography in all cases of spontaneous hyphema.

Entities:  

Mesh：

Year:  1975        PMID： 1180751     DOI： 10.1001/archopht.1975.01010020830018

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


  7 in total

1.  Transient monocular obscuration--amaurosis fugax?

Authors:  R S Manor
Journal:  Br J Ophthalmol       Date:  1986-12       Impact factor: 4.638

2.  Light microscopic and electron microscopic histopathology of an iris microhaemangioma.

Authors:  K V Meades; I C Francis; M B Kappagoda; M Filipic
Journal:  Br J Ophthalmol       Date:  1986-04       Impact factor: 4.638

3.  Spontaneous anterior chamber hemorrhage from the iris: a unique cinematographic documentation.

Authors:  R B Welch
Journal:  Trans Am Ophthalmol Soc       Date:  1980

4.  Microhaemangiomas of the iris with spontaneous hyphaema and acute glaucoma.

Authors:  H D Perry; F J Mallen; W Sussman
Journal:  Br J Ophthalmol       Date:  1977-02       Impact factor: 4.638

5.  Argon laser treatment of an abnormal angle vessel producing recurrent hyphema.

Authors:  L R de Corral; M Conway; G A Peyman; A Constanteras
Journal:  Int Ophthalmol       Date:  1985-09       Impact factor: 2.031

6.  Iris microhaemangioma: a management strategy.

Authors:  Aruna Dharmasena; Simon Wallis
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

7.  Spontaneous hyphaema secondary to bleeding from an iris vascular tuft in a patient with a supratherapeutic International normalised ratio: case report.

Authors:  Kenneth G J Ooi; Rohan Gupta; Sarah B Wang; Samuel Dance; Armand Borovik; Ian C Francis
Journal:  BMC Ophthalmol       Date:  2015-06-14       Impact factor: 2.209
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.